Drug
Edp 721
Edp 721: highest development phase Phase 1, developed by Enanta Pharmaceuticals. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Enanta Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| EDP-721 NCT04971512 | Phase 1 | Chronic Hepatitis B Virus Infection |
Latest
No recent events.
Follow Edp 721 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.